Moffitt Cancer Center is a clinical research site located in Tampa, Florida, United States 33612.
Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.
Moffitt Cancer Center has participated in 1026 clinical trials with 548 currently active.
Therapeutic areas: Breast Cancer, Renal Cell Carcinoma, Bladder Urothelial Carcinoma.
Sponsors: Infinity Pharmaceuticals, Inc., National Cancer Institute (NCI), Kestrel Therapeutics, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Florida · View every site in Tampa
Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Moffitt Cancer Center has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Moffitt Cancer Center has 1026 clinical trials on record, with 548 currently active. Their work covers Breast Cancer, Renal Cell Carcinoma, Bladder Urothelial Carcinoma.
Moffitt Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.